Paramount Bio-Tech Industries Limited

Paramount Bio-Tech Industries Limited - agriculture in New Delhi, Delhi, India. FY 2026 financials & compliance.
CIN U24231DL1996PLC082959 Incorporated 29 October 1996 ROC Delhi HQ New Delhi, Delhi, India
Active Public Limited Company agriculture
Data last updated
Revenue · FY 2025
₹5.47 Lakh
▼ 43% YoY
Net loss · FY 2025
₹13.45 Lakh
Net margin -246.1%
EBITDA · FY 2025
-₹14.91 Lakh
EBITDA margin -272.8%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹18.02 Lakh
Issued & subscribed
Company age
30 yrs
Est. 1996
Directors on board
5
As per MCA filings
Last financials
Mar 2025
Balance sheet date

About Paramount Bio-Tech Industries Limited

Data last updated:

Paramount Bio-Tech Industries Limited is a public limited company based in New Delhi, Delhi, India. It operates in the agricultural support and advisory segment of the agriculture sector. It was incorporated on 29 October 1996 and has been in existence for over 30 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24231DL1996PLC082959.

The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹18.02 Lakh. It is led by directors including Madhu Kokra and Pushpa Gupta.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at F 7 Iiird Floor East Of Kailash, New Delhi, Delhi, India – 110065.

As per the financials filed for FY 2025, the company reported a revenue of ₹5.47 Lakh, a decline of 43% compared to the previous year. For the same year it recorded a net loss of ₹13.45 Lakh (net margin -246.1%) and EBITDA of -₹14.91 Lakh (EBITDA margin -272.8%). Revenue has declined at a compounded annual rate (CAGR) of 36% over three years and 30% over five years.

Court records list 6 cases involving the company, including 6 filed against it; 2 cases are pending.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24231DL1996PLC082959
Registration Number 082959
Incorporation Date 29 October 1996
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant

Contact details

Paramount Bio-Tech Industries Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    F 7 Iiird Floor East Of Kailash, New Delhi, Delhi, India – 110065
  • Industry
    Agriculture, Agri Support Services

To see the full contact details of Paramount Bio-Tech Industries Limited, buy the company report.

Comprehensive company report
Paramount Bio-Tech Industries Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Paramount Bio-Tech Industries is agriculture, forestry, fishing. In detail, this covers production of crops and animals.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
AAgriculture, forestry, fishingA1Production of crops and animals

To see the full business activity and turnover split of Paramount Bio-Tech Industries Limited, buy the company report.

Financials of Paramount Bio-Tech Industries Limited

FY 2025 filings available

Paramount Bio-Tech Industries Limited reported revenue of ₹5.47 Lakh (down 43% YoY) for FY 2025.

Revenue · FY 2025
₹5.47 Lakh ▼ 43%
Net loss · FY 2025
₹13.45 Lakh margin -246.1%
EBITDA · FY 2025
-₹14.91 Lakh margin -272.8%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 43%
3 years · compounded
▼ 36%
5 years · compounded
▼ 30%
EBITDA CAGR growth
1 year
▲ 3%
3 years · compounded
▼ 37%
5 years · compounded
▼ 25%

Revenue has declined at a compounded annual rate (CAGR) of 30% over five years, including a 43% fall in the latest year. EBITDA rose 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹14.91 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹13.45 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin-272.8%
Net Profit Margin-246.1%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Paramount Bio-Tech Industries Limited, buy the company report.

Board of directors of Paramount Bio-Tech Industries Limited

Paramount Bio-Tech Industries has 5 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Pankaj Kumar PandeyAdditional Director25 Oct 20251 Years 0 MonthsCurrent
Madhu KokraDirector01 Oct 20188 Years 0 MonthsCurrent
Supriya AronAdditional Director07 Nov 20250 Years 11 MonthsCurrent
Pushpa GuptaDirector08 Dec 199728 Years 10 MonthsCurrent
Bhawani SrivastavaDirector11 Jan 20233 Years 9 MonthsCurrent

Auditor

Paramount Bio-Tech Industries Limited is audited by ALOK MITTAL & ASSOCIATES for the financial year 2022.

Auditor firmFinancial yearFirm registration number
ALOK MITTAL & ASSOCIATESFY 202271205

Shareholding

The shareholding of Paramount Bio-Tech Industries Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2021FY 2020FY 2019FY 2018FY 2017
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Paramount Bio-Tech Industries Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Paramount Bio-Tech Industries Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Group structure & subsidiaries

Paramount Bio-Tech Industries has 1 associated company. This group structure data is as of FY 2021. The table lists each entity with its relationship and holding.

1
Associated companies

GST

No GST registration is on our record for Paramount Bio-Tech Industries Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Paramount Bio-Tech Industries Limited has 12 board changes on record since 1997: 5 appointments and 7 cessations. The latest: Supriya Aron was appointed as Additional Director on 07 Nov 2025.

Appointed
Supriya Aron was appointed as Additional Director.
Appointed
Pankaj Kumar Pandey was appointed as Additional Director.
Ceased
Pushpa Gupta ceased to be Director.
AGM
Paramount Bio-Tech Industries Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Paramount Bio-Tech Industries Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Appointed
Bhawani Srivastava was appointed as Director.
Ceased
Madhu Kokra ceased to be Additional Director.
Ceased
Girish Chandra Gupta ceased to be Director.
Appointed
Madhu Kokra was appointed as Director.
Ceased
Madhur Chandra Gupta ceased to be Additional Director.
Ceased
Bhawani Srivastava ceased to be Director.
Ceased
Meena Gupta ceased to be Additional Director.

3 earlier events are in the company report.

Frequently asked questions

Paramount Bio-Tech Industries is an active public limited company based in New Delhi, Delhi, India. The company works in agri support services, within the agriculture industry. It was incorporated on 29 October 1996 (30+ years old) and is registered under CIN U24231DL1996PLC082959.

Paramount Bio-Tech Industries has 5 current directors:

The latest financial statements of Paramount Bio-Tech Industries on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The CIN (Corporate Identification Number) of Paramount Bio-Tech Industries is U24231DL1996PLC082959. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Paramount Bio-Tech Industries has 6 court cases on record: 6 filed against it. 2 are pending. Most are in the district courts.

Paramount Bio-Tech Industries was incorporated on 29 October 1996, making it 30+ years old. It is registered with the Registrar of Companies, Delhi.

Supriya Aron was appointed as Additional Director on 07 Nov 2025. Pankaj Kumar Pandey was appointed as Additional Director on 25 Oct 2025. Pushpa Gupta ceased to be Director on 25 Oct 2025. Paramount Bio-Tech Industries has 12 board changes on record in total.

The registered office of Paramount Bio-Tech Industries is at F 7 Iiird Floor East Of Kailash, New Delhi, Delhi, India – 110065.

Paramount Bio-Tech Industries operates in the agriculture industry, in the agri support services segment.

The compliance status of Paramount Bio-Tech Industries is compliant as of 23 August 2026. The company is actively filing with the Registrar of Companies.